Stem cells and the aging hematopoietic system

Current Opinion in Immunology

Volumn 22, Issue 4, 2010, Pages 500-506

  Beerman, Isabel ^a   Maloney, William J ^b   Weissmann, Irving L ^c   Rossi, Derrick J ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c STANFORD CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; AZACITIDINE; BCR ABL PROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; ADAPTIVE IMMUNITY; AGING; ANEMIA; AUTOIMMUNE DISEASE; CELL AGING; CELL COMPARTMENTALIZATION; CELL FUNCTION; CELL LINEAGE; CELL LOSS; CELL REGENERATION; CELL SUBPOPULATION; CLINICAL TRIAL; DNA METHYLATION; EFFECTOR CELL; GENETIC EPIGENESIS; GENETIC REGULATION; HEMATOPOIETIC STEM CELL; HUMAN; IMMUNOCOMPETENCE; LYMPHOPROLIFERATIVE DISEASE; MALIGNANT TRANSFORMATION; MYELODYSPLASTIC SYNDROME; NONHUMAN; PATHOPHYSIOLOGY; REVIEW; STEM CELL EXPANSION;

ADAPTIVE IMMUNITY; AGING; CELL AGING; HEMATOPOIETIC STEM CELLS; HEMATOPOIETIC SYSTEM; HUMANS;

EID: 77955658323     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coi.2010.06.007     Document Type: Review

References (50)

1. Rossi D.J., Jamieson C.H., Weissman I.L. Stems cells and the pathways to aging and cancer. Cell 2008, 132:681-696.
2. Harrison D.E. Mouse erythropoietic stem cell lines function normally 100 months: loss related to number of transplantations. Mech Ageing Dev 1979, 9:427-433.
3. Ogawa T., Kitagawa M., Hirokawa K. Age-related changes of human bone marrow: a histometric estimation of proliferative cells, apoptotic cells, T cells, B cells and macrophages. Mech Ageing Dev 2000, 117:57-68.
4. Pawelec G., Hirokawa K., Fulop T. Altered T cell signalling in ageing. Mech Ageing Dev 2001, 122:1613-1637.
5. Goronzy J.J., Lee W.W., Weyand C.M. Aging and T-cell diversity. Exp Gerontol 2007, 42:400-406.
6. Franceschi C., Bonafe M., Valensin S., Olivieri F., De Luca M., Ottaviani E., De Benedictis G. Inflamm-aging. An evolutionary perspective on immunosenescence. Ann N Y Acad Sci 2000, 908:244-254.
7. Dorshkind K., Swain S. Age-associated declines in immune system development and function: causes, consequences, and reversal. Curr Opin Immunol 2009, 21:404-407.
8. Linton P.J., Dorshkind K. Age-related changes in lymphocyte development and function. Nat Immunol 2004, 5:133-139.
9. Tsaknaridis L., Spencer L., Culbertson N., Hicks K., LaTocha D., Chou Y.K., Whitham R.H., Bakke A., Jones R.E., Offner H., et al. Functional assay for human CD4+CD25+ Treg cells reveals an age-dependent loss of suppressive activity. J Neurosci Res 2003, 74:296-308.
10. Kim M., Moon H.B., Spangrude G.J. Major age-related changes of mouse hematopoietic stem/progenitor cells. Ann N Y Acad Sci 2003, 996:195-208.
11. Rossi D.J., Bryder D., Zahn J.M., Ahlenius H., Sonu R., Wagers A.J., Weissman I.L. Cell intrinsic alterations underlie hematopoietic stem cell aging. Proc Natl Acad Sci USA 2005, 102:9194-9199.
12. Morrison S.J., Wandycz A.M., Akashi K., Globerson A., Weissman I.L. The aging of hematopoietic stem cells. Nat Med 1996, 2:1011-1016.
13. Sudo K., Ema H., Morita Y., Nakauchi H. Age-associated characteristics of murine hematopoietic stem cells. J Exp Med 2000, 192:1273-1280.
14. Rossi D.J., Bryder D., Seita J., Nussenzweig A., Hoeijmakers J., Weissman I.L. Deficiencies in DNA damage repair limit the function of haematopoietic stem cells with age. Nature 2007, 447:725-729.
15. Park Y., Gerson S.L. DNA repair defects in stem cell function and aging. Annu Rev Med 2005, 56:495-508.
16. Nijnik A., Woodbine L., Marchetti C., Dawson S., Lambe T., Liu C., Rodrigues N.P., Crockford T.L., Cabuy E., Vindigni A., et al. DNA repair is limiting for haematopoietic stem cells during ageing. Nature 2007, 447:686-690.
17. Navarro S., Meza N.W., Quintana-Bustamante O., Casado J.A., Jacome A., McAllister K., Puerto S., Surralles J., Segovia J.C., Bueren J.A. Hematopoietic dysfunction in a mouse model for Fanconi anemia group D1. Mol Ther 2006, 14:525-535.
18. Reese J.S., Liu L., Gerson S.L. Repopulating defect of mismatch repair-deficient hematopoietic stem cells. Blood 2003, 102:1626-1633.
19. Cho R.H., Sieburg H.B., Muller-Sieburg C.E. A new mechanism for the aging of hematopoietic stem cells: aging changes the clonal composition of the stem cell compartment but not individual stem cells. Blood 2008, 111:5553-5561.
20. Guerrettaz L.M., Johnson S.A., Cambier J.C. Acquired hematopoietic stem cell defects determine B-cell repertoire changes associated with aging. Proc Natl Acad Sci USA 2008, 105:11898-11902.
21. Liang Y., Van Zant G., Szilvassy S.J. Effects of aging on the homing and engraftment of murine hematopoietic stem and progenitor cells. Blood 2005, 106:1479-1487.
22. Edwards B.K., Howe H.L., Ries L.A., Thun M.J., Rosenberg H.M., Yancik R., Wingo P.A., Jemal A., Feigal E.G. Annual report to the nation on the status of cancer, 1973-1999, featuring implications of age and aging on U.S. cancer burden. Cancer 2002, 94:2766-2792.
23. United States Cancer Statistics, 1999-2005 Incidence Results on World Wide Web URL: http://wonder.cdc.gov/cancer-v2005.HTML.
24. Signer R.A., Montecino-Rodriguez E., Witte O.N., McLaughlin J., Dorshkind K. Age-related defects in B lymphopoiesis underlie the myeloid dominance of adult leukemia. Blood 2007, 110:1831-1839.
25. de Haan G., Nijhof W., Van Zant G. Mouse strain-dependent changes in frequency and proliferation of hematopoietic stem cells during aging: correlation between lifespan and cycling activity. Blood 1997, 89:1543-1550.
26. Pearce D.J., Anjos-Afonso F., Ridler C.M., Eddaoudi A., Bonnet D. Age-dependent increase in side population distribution within hematopoiesis: implications for our understanding of the mechanism of aging. Stem Cells 2007, 25:828-835.
27. Waterstrat A., Oakley E., Miller A., Swiderski C., Liang Y., Van Zant G. Mechanisms of stem cell ageing. Telomeres and Telomerase in Ageing, Disease, and Cancer 2008, 111-140. Springer. K.L. Rudolph (Ed.).
28. Majeti R., Park C.Y., Weissman I.L. Identification of a hierarchy of multipotent hematopoietic progenitors in human cord blood. Cell Stem Cell 2007, 1:635-645.
29. Ishikawa F., Yasukawa M., Lyons B., Yoshida S., Miyamoto T., Yoshimoto G., Watanabe T., Akashi K., Shultz L.D., Harada M. Development of functional human blood and immune systems in NOD/SCID/IL2 receptor {gamma} chain(null) mice. Blood 2005, 106:1565-1573.
30. Michallet M., Philip T., Philip I., Godinot H., Sebban C., Salles G., Thiebaut A., Biron P., Lopez F., Mazars P., et al. Transplantation with selected autologous peripheral blood CD34+Thy1+ hematopoietic stem cells (HSCs) in multiple myeloma: impact of HSC dose on engraftment, safety, and immune reconstitution. Exp Hematol 2000, 28:858-870.
31. Negrin R.S., Atkinson K., Leemhuis T., Hanania E., Juttner C., Tierney K., Hu W.W., Johnston L.J., Shizurn J.A., Stockerl-Goldstein K.E., et al. Transplantation of highly purified CD34+Thy-1+ hematopoietic stem cells in patients with metastatic breast cancer. Biol Blood Marrow Transplant 2000, 6:262-271.
32. Vose J.M., Bierman P.J., Lynch J.C., Atkinson K., Juttner C., Hanania C.E., Bociek G., Armitage J.O. Transplantation of highly purified CD34+Thy-1+ hematopoietic stem cells in patients with recurrent indolent non-Hodgkin's lymphoma. Biol Blood Marrow Transplant 2001, 7:680-687.
33. Taraldsrud E., Grogaard H.K., Solheim S., Lunde K., Floisand Y., Arnesen H., Seljeflot I., Egeland T. Age and stress related phenotypical changes in bone marrow CD34+ cells. Scand J Clin Lab Invest 2009, 69:79-84.
34. Muller-Sieburg C.E., Cho R.H., Karlsson L., Huang J.F., Sieburg H.B. Myeloid-biased hematopoietic stem cells have extensive self-renewal capacity but generate diminished lymphoid progeny with impaired IL-7 responsiveness. Blood 2004, 103:4111-4118.
35. Dykstra B., Kent D., Bowie M., McCaffrey L., Hamilton M., Lyons K., Lee S.J., Brinkman R., Eaves C. Long-term propagation of distinct hematopoietic differentiation programs in vivo. Cell Stem Cell 2007, 1:218-229.
36. Beerman I., Bhattacharya D., Zandi S., Sigvardsson M., Weissman I.L., Bryder D., Rossi D.J. Functionally distinct hematopoietic stem cells modulate hematopoietic lineage potential during aging by a mechanism of clonal expansion. Proc Natl Acad Sci USA 2010, 107:5465-5470.
37. Challen G.A., Boles N.C., Chambers S.M., Goodell M.A. Distinct hematopoietic stem cell subtypes are differentially regulated by TGF-beta1. Cell Stem Cell 2010, 6:265-278.
38. Morita Y., Ema H., Nakauchi H. Heterogeneity and hierarchy within the most primitive hematopoietic stem cell compartment. J Exp Med 2010, 207:1173-1182.
39. Attema J.L., Papathanasiou P., Forsberg E.C., Xu J., Smale S.T., Weissman I.L. Epigenetic characterization of hematopoietic stem cell differentiation using miniChIP and bisulfite sequencing analysis. Proc Natl Acad Sci USA 2007, 104:12371-12376.
40. Maes J., Maleszewska M., Guillemin C., Pflumio F., Six E., Andre-Schmutz I., Cavazzana-Calvo M., Charron D., Francastel C., Goodhardt M. Lymphoid-affiliated genes are associated with active histone modifications in human hematopoietic stem cells. Blood 2008, 112:2722-2729.
41. Weishaupt H., Sigvardsson M., Attema J.L. Epigenetic chromatin states uniquely define the developmental plasticity of murine hematopoietic stem cells. Blood 2010, 115:247-256.
42. Cui K., Zang C., Roh T.Y., Schones D.E., Childs R.W., Peng W., Zhao K. Chromatin signatures in multipotent human hematopoietic stem cells indicate the fate of bivalent genes during differentiation. Cell Stem Cell 2009, 4:80-93.
43. Kao J.M., McMillan A., Greenberg P.L. International MDS risk analysis workshop (IMRAW)/IPSS reanalyzed: impact of cytopenias on clinical outcomes in myelodysplastic syndromes. Am J Hematol 2008, 83:765-770.
44. Dhodapkar M., Grill J., Lust J.A. Abnormal regional hypermethylation of the calcitonin gene in myelodysplastic syndromes. Leuk Res 1995, 19:719-726.
45. Quesnel B., Guillerm G., Vereecque R., Wattel E., Preudhomme C., Bauters F., Vanrumbeke M., Fenaux P. Methylation of the p15(INK4b) gene in myelodysplastic syndromes is frequent and acquired during disease progression. Blood 1998, 91:2985-2990.
46. Tien H.F., Tang J.H., Tsay W., Liu M.C., Lee F.Y., Wang C.H., Chen Y.C., Shen M.C. Methylation of the p15(INK4B) gene in myelodysplastic syndrome: it can be detected early at diagnosis or during disease progression and is highly associated with leukaemic transformation. Br J Haematol 2001, 112:148-154.
47. Jones P.A., Taylor S.M. Cellular differentiation, cytidine analogs and DNA methylation. Cell 1980, 20:85-93.
48. Silverman L.R., Demakos E.P., Peterson B.L., Kornblith A.B., Holland J.C., Odchimar-Reissig R., Stone R.M., Nelson D., Powell B.L., DeCastro C.M., et al. Randomized controlled trial of azacitidine in patients with the myelodysplastic syndrome: a study of the cancer and leukemia group B. J Clin Oncol 2002, 20:2429-2440.
49. Fukumoto J.S., Greenberg P.L. Management of patients with higher risk myelodysplastic syndromes. Crit Rev Oncol Hematol 2005, 56:179-192.
50. Daskalakis M., Nguyen T.T., Nguyen C., Guldberg P., Kohler G., Wijermans P., Jones P.A., Lubbert M. Demethylation of a hypermethylated P15/INK4B gene in patients with myelodysplastic syndrome by 5-Aza-2'-deoxycytidine (decitabine) treatment. Blood 2002, 100:2957-2964.